Medacta Group (CHIX:MOVEZ) EPS (Basic): CHF4.48 (TTM As of Dec. 2025)


CHIX:MOVEZ Medacta Group SA CHIX:MOVEZ
92 GF Score
Price CHF136.20
GF Value CHF167.40
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medacta Group EPS (Basic)?

Medacta Group CHIX:MOVEZ +2.25% 92 EPS (Basic) is CHF4.48 as of Dec. 2025. GuruFocus rates CHIX:MOVEZ with a GF Score™ of 92/100 and a GF Value™ of CHF167.40 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Medacta Group's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was CHF1.66. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF4.48.

Medacta Group's EPS (Diluted) for the six months ended in Dec. 2025 was CHF1.65. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF4.48.

Medacta Group's EPS without NRI for the six months ended in Dec. 2025 was CHF1.56. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 3.82.

During the past 12 months, Medacta Group's average EPS without NRIGrowth Rate was 8.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 18.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Medacta Group's highest 3-Year average EPS without NRI Growth Rate was 51.90% per year. The lowest was -32.60% per year. And the median was 3.80% per year.

Medacta Group  (CHIX:MOVEz) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medacta Group EPS (Basic) Related Terms

Medacta Group EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Medacta Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medacta Group EPS (Basic) Chart

Medacta Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.69 2.29 2.24 3.42 4.47

Medacta Group Semi-Annual Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 1.84 1.63 2.82 1.66
CHIX:MOVEZ
92GF Score
Medacta Group SA CHIX:MOVEZ
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medacta Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medacta Group's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(89.077-0)/19.927
=4.47

Medacta Group's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(33.053-0)/19.925
=1.66

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF4.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of CHF4.48 mean?
Medacta Group (CHIX:MOVEZ) has a EPS (Basic) of CHF4.48 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medacta Group and its competitors.
Is Medacta Group's EPS (Basic) too high?
Medacta Group's current EPS (Basic) is CHF4.48. Overall, Medacta Group has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's EPS (Basic) compare to ABT and SYK?
Medacta Group's EPS (Basic) of CHF4.48 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medacta Group and its competitors. Medacta Group's current EPS (Basic) is CHF4.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Based on GuruFocus' analysis, Medacta Group (CHIX:MOVEZ) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF167.40, compared to a current price of CHF136.20 — trading 18.6% below its estimated fair value. The current EPS (Basic) is CHF4.48. Medacta Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Medacta Group (CHIX:MOVEZ), the current EPS (Basic) is CHF4.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medacta Group (CHIX:MOVEZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued. The current stock price of CHF136.20 is trading 18.6% below its estimated GF Value™ of CHF167.40. GuruFocus considers Medacta Group to be Modestly Undervalued.

Key valuation signals for CHIX:MOVEZ:

  • EPS (Basic): CHF4.48
  • GF Value™: CHF167.40 vs. price of CHF136.20 (18.6% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the CHIX:MOVEZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medacta Group Business Description

Address Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
92GF Score

Get the complete analysis for CHIX:MOVEZ

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF136.20
Price
CHF167.40
GF Value